modifying schizophrenia- antipsychotics evaluation
- Created by: Elyseee
- Created on: 29-01-21 14:06
View mindmap
- antipsychotics evaluation
- Ineffectiveness - Non-compliance
- Non compliance of patients in taking the medication makes it difficult to assess the efficacy of the treatment
- Rettenbacher 2004 found that only 54.2% of individuals with schizophrenia fully complied with the dosage requirements
- This may be because people who suffer from schizophrenia lack insight into their condition and may not understand that they have a problem which requires medication
- Ethical issues - Side effects
- Side effects such as tardive dyskinesia ( uncontrollable tics) and parkinsonism ( tremors and instability) and seizures may not be explained or understood by a patient
- Furthermore if someone is experiencing an acute episode the drug may be administered without consent
- Social implications - Risk of violence
- One serious consequence of non compliance with drug treatment is that individuals who are suffering from schizophrenia may be at serious risk of harming themselves or others
- Tihonen 2006 noted a 37 fold increase in suicide amongst those who stopped taking their medication
- The NICSH 2015 report that 346 homicides were committed in England by people with a history of schizophrenia between 2003 and 2013 with 29% of these individuals not adhering to their treatment regime in the previous month
- Effectiveness - research support
- Cole et al ( 1964) found that 75% of those given a conventional antipsychotic were considered to be much improved compared with 25% of those given a placebo
- In addition none of the patients given antipsychotics appear to “get worse” whereas 48% of those given the placebo did
- Ineffectiveness - Non-compliance
Comments
No comments have yet been made